- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2005
- Public Summary Document (PSD) November 2005 PBAC Meeting - PDF
Buprenorphine hydrochloride with naloxone hydrochloride – November 2005
Buprenorphine hydrochloride with naloxone hydrochloride, sublingual tablets, 2 mg (base) - 500 micrograms and 8 mg (base) – 2 mg, Suboxone®, November 2005
Last updated
27 February 2006
